Report Highlights
A recent market study published by FMI on MEA Biologics and Biosimilar offers a global industry analysis for 2017-2022 and opportunity assessment for 2023-2033. The study offers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historical and current growth parameters, the growth prospects of the market are obtained with maximum precision.
Market Segmentation
By Drug:
- Adalimumab
- Bevacizumab
- Trastuzumab
- Ustekinumab
- Golimumab
- Eculizumab
- Rituximab
By Drug Class:
- Antirheumatics
- TNF Alfa Inhibitors
- VEGF/VEGFR Inhibitors
- HER2 Inhibitors
- Selective Immunosuppressant’s
- Interleukin Inhibitors
By Dosage Form:
- Subcutaneous
- Intravenous
By Indication:
- Cancer
- Arthritis
- Rheumatoid
- Psoriatic
- Others
- Skin Disorders
- Plaque-Type Psoriasis
- Hidradenitis Suppurativa
- Inflammatory Bowel Disease (IBD)
- Crohn's Disease
- Ulcerative Colitis
- Rare Disease
- Others
By Distribution Channel:
- Hospitals
- Specialty Clinics
- Cancer Research Centers
- Retail Sales
- Retail Pharmacies
- Mail Order Pharmacies /Online Sales
By Country:
- UAE
- Bahrain
- Iraq
- Jordan
- Kuwait
- Lebanon
- Oman
- Qatar
- KSA
- Iran
- Palestine
Report Chapters
Executive Summary
The executive summary of the MEA Biologics and Biosimilar Market includes the global market outlook, demand side trends, supply side trends and also include FMI analysis and recommendations of Vehicle Radar Test System.
Chapter 01 - Market Overview
Readers can find the detailed segmentation and definition of the MEA Biologics and Biosimilar Market in this chapter, which will help to understand basic information about Vehicle Radar Test System. This section also highlights the market scope, taxonomy and limitations which help the reader understand the market coverage of MEA Biologics and Biosimilar Market report.
Chapter 02 - Market Background
This chapter includes detailed analysis of the By Drug processing methods overview, consumer buying patterns & tendencies and policy developments and regulatory scenario. It also includes in depth analysis of macro-economic factors and covers topics like global GDP growth outlook, global industry value added, personal consumption, expenditures, modern trade penetration and consumer price indices. The chapter also covers forecast factors - relevance & impact, value chain analysis and market dynamics (drivers, restraints and opportunities) to better understand the market.
Chapter 03 - Global MEA Biologics and Biosimilar Market Demand Analysis 2017-2022 and Forecast, 2023-2033
The chapter include historical market value (US$ 485.9 Million) analysis (2017-2022) and current and future market value (US$ 512.6 Million) and volume (5.5%) projections (2023-2033). The projections are based on the Y-O-Y growth trend analysis and absolute $ opportunity analysis country of operation.
Chapter 04 - Global MEA Biologics and Biosimilar Market - Pricing Analysis
Based on By Drug, the pricing analysis chapter include Regional pricing analysis (USD/MT), global average pricing analysis benchmark, and key factors impacting the pricing.
Chapter 05 - Global MEA Biologics and Biosimilar Market Analysis 2017-2022 and Forecast 2023-2033, By Drug
Based on By Drug, MEA Biologics and Biosimilar Market is segmented into Adalimumab, Bevacizumab, Trastuzumab, Ustekinumab, Golimumab, Eculizumab, Rituximab. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Drug.
Chapter 06 - Global MEA Biologics and Biosimilar Market Analysis 2017-2022 and Forecast 2023-2033, By Drug Class
Based on By Drug Class, MEA Biologics and Biosimilar Market is segmented into Antirheumatics, TNF Alfa Inhibitors, VEGF/VEGFR Inhibitors, HER2 Inhibitors, Selective Immunosuppressant’s, Interleukin Inhibitors. This section also offers market attractiveness analysis based on By Drug Class. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Drug Class.
Chapter 07 - Global MEA Biologics and Biosimilar Market Analysis 2017-2022 and Forecast 2023-2033, By Dosage Form
Based on By Dosage Form, MEA Biologics and Biosimilar Market is segmented into Subcutaneous, Intravenous. This section also offers market attractiveness analysis based on By Dosage Form. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Dosage Form.
Chapter 08 - Global MEA Biologics and Biosimilar Market Analysis 2017-2022 and Forecast 2023-2033, By Indication
Based on By Indication, MEA Biologics and Biosimilar Market is segmented into Cancer, Arthritis (Rheumatoid, Psoriatic, Others), Skin Disorders (Plaque-Type Psoriasis, Hidradenitis Suppurativa), Inflammatory Bowel Disease (IBD)(Crohn's Disease, Ulcerative Colitis), Rare Disease, Others. This section also offers market attractiveness analysis based on By Indication. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Indication.
Chapter 09 - Global MEA Biologics and Biosimilar Market Analysis 2017-2022 and Forecast 2023-2033, By Distribution Channel
Based on By Distribution Channel, MEA Biologics and Biosimilar Market is segmented into Hospitals (Specialty Clinics, Cancer Research Centers), Retail Sales (Retail Pharmacies, Mail Order Pharmacies /Online Sales). This section also offers market attractiveness analysis based on By Distribution Channel. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Distribution Channel.
Chapter 10 - MEA Biologics and Biosimilar Market Analysis 2017-2022 and Forecast 2023-2033, By Country
Based on By Country, MEA Biologics and Biosimilar Market is segmented into UAE, Bahrain, Iraq, Jordan, Kuwait, Lebanon, Oman, Qatar, KSA, Iran, Palestine. This section also offers market attractiveness analysis based on By Country. Readers can also find value forecast and Y-o-Y growth comparison for all above mentioned By Country.
Report Synopsis
| Report Metrics | Details |
| Base year considered | 2023 |
| Forecast period considered | 2023-2033 |
| Units considered | $ Million |
| Segments covered | By Drug , By Drug Class, By Dosage Form, By Indication, By Distribution Channel, By Country |
| Industry covered | Healthcare |
| Countries covered | UAE, Bahrain, Iraq, Jordan, Kuwait, Lebanon, Oman, Qatar, KSA, Iran, Palestine |
| Companies studied |
|
Chapter 11 - Key Countries MEA Biologics and Biosimilar Market Analysis 2017-2022 and Forecast 2023-2033
This chapter offers insights into how the MEA Biologics and Biosimilar Market is expected to grow in major countries globally.
Chapter 12 - Market Structure Analysis- Global Assessment
This chapter includes company dashboard, industry structure analysis by tier of companies, 2022E, company share analysis of top players, 2022E, and competition benchmarking- matrix.
Chapter 13 - Competition Deep Dive (Tentative List)
This chapter includes company overview, By Drug portfolio of companies, profitability by market segments, sales footprint, SWOT analysis and strategy overview of the companies being studied in the report. Some of the market players featured in the report are AbbVie Inc., Eisai Co Ltd, Zydus Cadila(Cadila Healthcare), Amneal Pharmaceuticals, Inc., Pfizer Inc., Celltrion, Inc., Coherus BioSciences, Inc., F. Hoffmann–La Roche Ltd (Genentech, Inc.), Alexion(Astrazeneca), Johnson & Johnson, Amgen, Hikma pharmaceuticals plc..
Chapter 14 - Assumptions and Acronyms
This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the Vehicle Radar Test System report.
Chapter 15 - Research Methodology
This chapter helps readers understand the research methodology followed to obtain various conclusions, as well as important qualitative and quantitative information, on MEA Biologics and Biosimilar Market.
- Table 1 : Market Demand Volume Analysis 2017 to 2022 and Forecast 2023 to 2033, by Drug
- Table 2 : Market Demand Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Drug
- Table 3 : Market Demand Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Drug Class
- Table 4 : Market Demand Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Dosage Form
- Table 5 : Market Demand Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Indication
- Table 6 : Market Demand Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Distribution Channel
- Table 7 : Market Demand Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Country
- Table 8 : UAE Market Demand Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Drug
- Table 9 : UAE Market Demand Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Drug Class
- Table 10 : UAE Market Demand Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Dosage Form
- Table 11 : UAE Market Demand Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Indication
- Table 12 : UAE Market Demand Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Distribution Channel
- Table 13 : Kuwait Market Demand Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Drug
- Table 14 : Kuwait Market Demand Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Drug Class
- Table 15 : Kuwait Market Demand Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Dosage Form
- Table 16 : Kuwait Market Demand Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Indication
- Table 17 : Kuwait Market Demand Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Distribution Channel
- Table 18 : Qatar Market Demand Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Drug
- Table 19 : Qatar Market Demand Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Drug Class
- Table 20 : Qatar Market Demand Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Dosage Form
- Table 21 : Qatar Market Demand Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Indication
- Table 22 : Qatar Market Demand Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Distribution Channel
- Table 23 : Bahrain Market Demand Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Drug
- Table 24 : Bahrain Market Demand Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Drug Class
- Table 25 : Bahrain Market Demand Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Dosage Form
- Table 26 : Bahrain Market Demand Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Indication
- Table 27 : Bahrain Market Demand Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Distribution Channel
- Table 28 : Oman Market Demand Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Drug
- Table 29 : Oman Market Demand Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Drug Class
- Table 30 : Oman Market Demand Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Dosage Form
- Table 31 : Oman Market Demand Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Indication
- Table 32 : Oman Market Demand Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Distribution Channel
- Table 33 : Lebanon Market Demand Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Drug
- Table 34 : Lebanon Market Demand Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Drug Class
- Table 35 : Lebanon Market Demand Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Dosage Form
- Table 36 : Lebanon Market Demand Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Indication
- Table 37 : Lebanon Market Demand Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Distribution Channel
- Table 38 : Jordan Market Demand Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Drug
- Table 39 : Jordan Market Demand Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Drug Class
- Table 40 : Jordan Market Demand Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Dosage Form
- Table 41 : Jordan Market Demand Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Indication
- Table 42 : Jordan Market Demand Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Distribution Channel
- Table 43 : Palestine Market Demand Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Drug
- Table 44 : Palestine Market Demand Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Drug Class
- Table 45 : Palestine Market Demand Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Dosage Form
- Table 46 : Palestine Market Demand Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Indication
- Table 47 : Palestine Market Demand Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Distribution Channel
- Table 48 : Iraq Market Demand Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Drug
- Table 49 : Iraq Market Demand Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Drug Class
- Table 50 : Iraq Market Demand Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Dosage Form
- Table 51 : Iraq Market Demand Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Indication
- Table 52 : Iraq Market Demand Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Distribution Channel
- Table 53 : KSA Market Demand Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Drug
- Table 54 : KSA Market Demand Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Drug Class
- Table 55 : KSA Market Demand Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Dosage Form
- Table 56 : KSA Market Demand Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Indication
- Table 57 : KSA Market Demand Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Distribution Channel
- Table 58 : Iran Market Demand Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Drug
- Table 59 : Iran Market Demand Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Drug Class
- Table 60 : Iran Market Demand Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Dosage Form
- Table 61 : Iran Market Demand Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Indication
- Table 62 : Iran Market Demand Market Size (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Distribution Channel
- Figure 1 : Market Volume Analysis, 2017 to 2022
- Figure 2 : MEA Average Drug Pricing Analysis Benchmark (US$), 2021
- Figure 3 : Market Value Analysis (US$ Million), 2017 to 2022
- Figure 4 : Market Share Analysis (%), By Drug, 2022A & 2023E
- Figure 5 : Market Share Analysis (%), By Drug Class, 2022A & 2023E
- Figure 6 : Market Share Analysis (%), By Dosage Form, 2022A & 2023E
- Figure 7 : Market Share Analysis (%), By Indication, 2022A & 2023E
- Figure 8 : Market Share Analysis (%), By Distribution Channel, 2022A & 2023E
- Figure 9 : Market Share Analysis (%), By Country, 2022A & 2023E
- Figure 10 : UAE Market Split By Drug 2022 (A)
- Figure 11 : UAE Market Split By Drug Class 2022 (A)
- Figure 12 : UAE Market Split By Dosage Form 2022 (A)
- Figure 13 : UAE Market Split By Indication 2022 (A)
- Figure 14 : UAE Market Split By Distribution Channel 2022 (A)
- Figure 15 : UAE Market Value Analysis (US$ Million), 2017 to 2022
- Figure 16 : Kuwait Market Split By Drug 2022 (A)
- Figure 17 : Kuwait Market Split By Drug Class 2022 (A)
- Figure 18 : Kuwait Market Split By Dosage Form 2022 (A)
- Figure 19 : Kuwait Market Split By Indication 2022 (A)
- Figure 20 : Kuwait Market Split By Distribution Channel 2022 (A)
- Figure 21 : Kuwait Market Value Analysis (US$ Million), 2017 to 2022
- Figure 22 : Qatar Market Split By Drug 2022 (A)
- Figure 23 : Qatar Market Split By Drug Class 2022 (A)
- Figure 24 : Qatar Market Split By Dosage Form 2022 (A)
- Figure 25 : Qatar Market Split By Indication 2022 (A)
- Figure 26 : Qatar Market Split By Distribution Channel 2022 (A)
- Figure 27 : Qatar Market Value Analysis (US$ Million), 2017 to 2022
- Figure 28 : Bahrain Market Split By Drug 2022 (A)
- Figure 29 : Bahrain Market Split By Drug Class 2022 (A)
- Figure 30 : Bahrain Market Split By Dosage Form 2022 (A)
- Figure 31 : Bahrain Market Split By Indication 2022 (A)
- Figure 32 : Bahrain Market Split By Distribution Channel 2022 (A)
- Figure 33 : Bahrain Market Value Analysis (US$ Million), 2017 to 2022
- Figure 34 : Oman Market Split By Drug 2022 (A)
- Figure 35 : Oman Market Split By Drug Class 2022 (A)
- Figure 36 : Oman Market Split By Dosage Form 2022 (A)
- Figure 37 : Oman Market Split By Indication 2022 (A)
- Figure 38 : Oman Market Split By Distribution Channel 2022 (A)
- Figure 39 : Oman Market Value Analysis (US$ Million), 2017 to 2022
- Figure 40 : Lebanon Market Split By Drug 2022 (A)
- Figure 41 : Lebanon Market Split By Drug Class 2022 (A)
- Figure 42 : Lebanon Market Split By Dosage Form 2022 (A)
- Figure 43 : Lebanon Market Split By Indication 2022 (A)
- Figure 44 : Lebanon Market Split By Distribution Channel 2022 (A)
- Figure 45 : Lebanon Market Value Analysis (US$ Million), 2017 to 2022
- Figure 46 : Jordan Market Split By Drug 2022 (A)
- Figure 47 : Jordan Market Split By Drug Class 2022 (A)
- Figure 48 : Jordan Market Split By Dosage Form 2022 (A)
- Figure 49 : Jordan Market Split By Indication 2022 (A)
- Figure 50 : Jordan Market Split By Distribution Channel 2022 (A)
- Figure 51 : Jordan Market Value Analysis (US$ Million), 2017 to 2022
- Figure 52 : Palestine Market Split By Drug 2022 (A)
- Figure 53 : Palestine Market Split By Drug Class 2022 (A)
- Figure 54 : Palestine Market Split By Dosage Form 2022 (A)
- Figure 55 : Palestine Market Split By Indication 2022 (A)
- Figure 56 : Palestine Market Split By Distribution Channel 2022 (A)
- Figure 57 : Palestine Market Value Analysis (US$ Million), 2017 to 2022
- Figure 58 : Iraq Market Split By Drug 2022 (A)
- Figure 59 : Iraq Market Split By Drug Class 2022 (A)
- Figure 60 : Iraq Market Split By Dosage Form 2022 (A)
- Figure 61 : Iraq Market Split By Indication 2022 (A)
- Figure 62 : Iraq Market Split By Distribution Channel 2022 (A)
- Figure 63 : Iraq Market Value Analysis (US$ Million), 2017 to 2022
- Figure 64 : KSA Market Split By Drug 2022 (A)
- Figure 65 : KSA Market Split By Drug Class 2022 (A)
- Figure 66 : KSA Market Split By Dosage Form 2022 (A)
- Figure 67 : KSA Market Split By Indication 2022 (A)
- Figure 68 : KSA Market Split By Distribution Channel 2022 (A)
- Figure 69 : KSA Market Value Analysis (US$ Million), 2017 to 2022
- Figure 70 : Iran Market Split By Drug 2022 (A)
- Figure 71 : Iran Market Split By Drug Class 2022 (A)
- Figure 72 : Iran Market Split By Dosage Form 2022 (A)
- Figure 73 : Iran Market Split By Indication 2022 (A)
- Figure 74 : Iran Market Split By Distribution Channel 2022 (A)
- Figure 75 : Iran Market Value Analysis (US$ Million), 2017 to 2022
Future Market Insights is the premier provider of market intelligence and consulting services, serving client in over 160 countries. FMI is headquartered in London, the global financial capital and has delivery centers in the U.S. and India. FMI's research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure that our clients prepare for the evolving needs of their customers. FMI's team of over 200 research analysts provides market intelligence at global, regional, and country levels. Our analysts are committed to provide independent insights, relying on our cognitive training modules, which conditions them to look at data objectively and unbiasedly. Others you can use from the file Allen just shared when those will be made live.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More